HIV research has come a long way since the virus was discovered in the 1980s. Antiretroviral therapy was a major milestone that has changed the lives of millions; the goal…
Here are the most innovative therapies presented by European biotechs fighting cancer during the ASCO 2017 meeting in Chicago. European biotech was in the spotlight during this year's edition of…
Here’s a list of the public European biotech companies that are worth more than a billion euros in 2022. European biotech is growing steadily and this year we welcome a…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled through. Let’s look back at some of the top moments in the last 12 months. …
Here are the top biotech companies in Oxford, a city with an old scientific tradition and an enormous output of biotech applications. Oxford is well known for its university, one…
UK biotech Immunocore has raised €116.7M in Series B funding to develop drugs that harness the body’s immune cells to fight cancer, viral infections, and autoimmune diseases. This latest funding…
Immunocore and the US biotech giant Genentech are building on their existing partnership to boost the clinical development of Immunocore's immunotherapy for treating solid tumors. In the agreement, Genentech, a…
Besides struggling with ambitious New Year’s resolutions and post-holiday diets, January is a time where many of us re-examine our finances and budget for the year ahead. With money on…
Still catching up on news? We've picked out the most exciting things that happened besides clinical results and finance. Here's the biggest biotech news of 2017. We've been recapping the…
The UK grants Immunocore access to a fast-track scheme that will make its immunotherapy IMCgp100 available to patients with uveal melanoma before approval. The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA)…
This week marks the WHO's World Antibiotic Awareness Week. We had a look at some of the best work being done by biotechs to fight resistance. An estimated 154 million prescriptions for antibiotics…
Immunocore, one of the only three European biotech unicorns, has presented Phase I results for its TCR immunotherapy IMCgp100 in patients suffering from metastatic uveal melanoma. Results are positive, but…